tacrolimus al 3 mg hartkapseln, retardiert
aliud pharma gmbh (3270510) - hartkapsel, retardiert - 3 mg
tacrolimus al 0,5 mg hartkapseln, retardiert
aliud pharma gmbh (3270510) - hartkapsel, retardiert - 0,5 mg
truqap 160 mg filmtabletten
astrazeneca ag - capivasertibum - filmtabletten - capivasertibum 160 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 1.82 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - mammakarzinom - synthetika
truqap 200 mg filmtabletten
astrazeneca ag - capivasertibum - filmtabletten - capivasertibum 200 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 2.28 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - mammakarzinom - synthetika
voriconazol hameln 200 mg pulver zur herstellung einer infusionslösung
hameln pharma gmbh (8084054) - pulver zur herstellung einer infusionslösung - 200 mg
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - schlaf initiation und wartung störungen - psycholeptika - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
quviviq 25 mg filmtabletten
idorsia pharmaceuticals ltd - daridorexantum - filmtabletten - daridorexantum 25 mg ut daridorexanti hydrochloridum, mannitolum, cellulosum microcristallinum, povidonum k 30, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, glycerolum, talcum, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto corresp. natrium 0.655 mg. - schlaflosigkeit - synthetika
quviviq 50 mg filmtabletten
idorsia pharmaceuticals ltd - daridorexantum - filmtabletten - daridorexantum 50 mg ut daridorexanti hydrochloridum, mannitolum, cellulosum microcristallinum, povidonum k 30, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, glycerolum, talcum, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum) pro compresso obducto corresp. natrium 0.655 mg. - schlaflosigkeit - synthetika
camzyos
bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - andere herzpräparate - treatment of symptomatic obstructive hypertrophic cardiomyopathy.
mysoline - tabletten
sanova pharma gmbh - primidon - primidon